Die Reproduzierbarkeit von Neuropad im Test-Retest-Verfahren erwies sich als robust.
A study entitled „Reproducibility of the New Indicator Test for Sudomotor Function (Neuropad®) in Patients with Type 2 Diabetes Mellitus“ was undertaken in University Hospital of Alexandroupolis, Greece to assess the reproducibility of Neuropad. In a 2005 short-communication study, the…